Subscribe To Our Free Newsletter |
Bajaj Healthcare zooms 53% in four weeks on healthy FY24 guidance
EBITDA margins would be in the range of 16 -20 per cent for the FY24, mainly driven by growth in the formulation biz and with the introduction of reverse engineering APIs launched in the last fiscal.